CY1106450T1 - Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους - Google Patents

Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους

Info

Publication number
CY1106450T1
CY1106450T1 CY20071100207T CY071100207T CY1106450T1 CY 1106450 T1 CY1106450 T1 CY 1106450T1 CY 20071100207 T CY20071100207 T CY 20071100207T CY 071100207 T CY071100207 T CY 071100207T CY 1106450 T1 CY1106450 T1 CY 1106450T1
Authority
CY
Cyprus
Prior art keywords
derivatives
bacteriochlorofoil
palladium
ch2oh
substituted
Prior art date
Application number
CY20071100207T
Other languages
Greek (el)
English (en)
Inventor
Avigdor Scherz
Yoram Salomon
Alexander Brandis
Hugo Scheer
Original Assignee
Yeda Research And Development Company, Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Company, Ltd. filed Critical Yeda Research And Development Company, Ltd.
Publication of CY1106450T1 publication Critical patent/CY1106450T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CY20071100207T 1998-12-09 2007-02-15 Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους CY1106450T1 (el)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98403110 1998-12-09
EP99958470A EP1137411B1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof
PCT/IL1999/000673 WO2000033833A1 (en) 1998-12-09 1999-12-09 Palladium-substituted bacteriochlorophyll derivatives and use thereof

Publications (1)

Publication Number Publication Date
CY1106450T1 true CY1106450T1 (el) 2011-10-12

Family

ID=8235584

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20071100207T CY1106450T1 (el) 1998-12-09 2007-02-15 Υποκατεστημενα με παλλαδιο βακτηριοχλωροφυλλικα παραγωγα και χρηση τους

Country Status (22)

Country Link
US (1) US6569846B1 (enExample)
EP (1) EP1137411B1 (enExample)
JP (1) JP4796227B2 (enExample)
CN (1) CN1160069C (enExample)
AT (1) ATE347554T1 (enExample)
AU (1) AU771292B2 (enExample)
BR (1) BRPI9916096B8 (enExample)
CA (1) CA2353554C (enExample)
CY (1) CY1106450T1 (enExample)
DE (1) DE69934328T2 (enExample)
DK (1) DK1137411T3 (enExample)
ES (1) ES2277454T3 (enExample)
HK (1) HK1040638B (enExample)
HU (1) HU228208B1 (enExample)
IL (1) IL143591A0 (enExample)
NO (1) NO331426B1 (enExample)
NZ (1) NZ512093A (enExample)
PL (1) PL201172B1 (enExample)
PT (1) PT1137411E (enExample)
RU (1) RU2234508C2 (enExample)
SI (1) SI1137411T1 (enExample)
WO (1) WO2000033833A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7897140B2 (en) * 1999-12-23 2011-03-01 Health Research, Inc. Multi DTPA conjugated tetrapyrollic compounds for phototherapeutic contrast agents
EP1318807A4 (en) * 2000-08-11 2008-02-20 Ceramoptec Gmbh LIGHT-SENSITIVE OINTMENT
EP1277470A1 (fr) * 2001-07-17 2003-01-22 Steba Biotech N.V. Formulation galénique injectable pour utilisation dans un diagnostic ou une thérapie photodynamique et son procédé de préparation
CA2485224A1 (en) * 2002-05-08 2003-11-20 Yeda Research And Development Co. Ltd. Sensitized online bold-mri imaging method
JP4529344B2 (ja) * 2002-06-03 2010-08-25 ニプロ株式会社 腫瘍組織の酸素濃度を上昇させるためのポルフィリン酸素輸液製剤
WO2004002476A2 (en) 2002-06-27 2004-01-08 Health Research, Inc. Fluorinated chlorin and bacteriochlorin photosensitizers for photodynamic therapy
US7053210B2 (en) * 2002-07-02 2006-05-30 Health Research, Inc. Efficient synthesis of pyropheophorbide a and its derivatives
IL152900A0 (en) 2002-11-17 2003-06-24 Yeda Res & Dev Water-soluble bacteriochlorophyll derivatives and their pharmaceutical uses
RU2257898C1 (ru) * 2004-03-22 2005-08-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Фотосенсибилизатор, липосомальная форма фотосенсибилизатора и способ проведения фотодинамической терапии
EP1753457B8 (en) * 2004-06-07 2016-09-21 Yeda Research And Development Co., Ltd. Cationic bacteriochlorophyll derivatives and uses thereof
GB2415372A (en) * 2004-06-23 2005-12-28 Destiny Pharma Ltd Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent
US20060222592A1 (en) * 2005-04-05 2006-10-05 Clemens Burda Nanoparticles and methods of manufacturing nanoparticles for electronic and non-electronic applications
US20110040170A1 (en) * 2008-01-28 2011-02-17 Yeda Research And Development Co., Ltd. Endoscopic imaging photodynamic therapy system and methods of use
PT2257309T (pt) 2008-02-27 2020-01-22 Yeda Res And Development Company Ltd Conjugados rgd-(bacterio)clorofila para utilização no diagnóstico de tumores compreendendo domínios necróticos
US20110070154A1 (en) * 2008-08-13 2011-03-24 Hyde Roderick A Artificial cells
GB0819594D0 (en) 2008-10-24 2008-12-03 Univ Coimbrra Process
EP2425873A1 (fr) 2010-09-07 2012-03-07 Steba Maor SA Modélisation de l'action d'une fibre optique dans un traitement par therapie photodynamique, et assistance à la planification d'un tel traitement
CN103405769A (zh) * 2013-03-07 2013-11-27 北京亿仁赛博医疗科技研发中心有限公司 光敏剂在制备治疗疾病的病毒灭活药物中的应用
WO2014140786A1 (en) 2013-03-11 2014-09-18 Steba Biotech S.A. Method for producing bacteriochlorophyll a
US10766915B2 (en) 2013-03-15 2020-09-08 Sherri Ann McFARLAND Metal-based coordination complexes as photodynamic compounds and their use
SG11201808849TA (en) 2016-04-10 2018-11-29 Yeda Res & Dev Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative
US10933134B2 (en) 2017-03-16 2021-03-02 Memorial Sloan Kettering Cancer Center Combination therapies for treatment of cancer
IL311461B2 (en) * 2024-03-13 2026-05-01 Impact Biotech Ltd Process for preparing palladium-bacteriophophorbide derivatives and their alkali metal salts

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5002962A (en) 1988-07-20 1991-03-26 Health Research, Inc. Photosensitizing agents
US5171741A (en) * 1989-04-21 1992-12-15 Health Research, Inc. Bacteriochlorophyll-a derivatives useful in photodynamic therapy
IL102645A (en) 1992-07-26 1998-02-22 Yeda Res & Dev Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
RU2063971C1 (ru) * 1993-11-05 1996-07-20 Московская государственная академия тонкой химической технологии им.М.В.Ломоносова Способ получения производного гематопорфирина
IL115744A (en) * 1994-10-27 2000-07-16 Akzo Nobel Nv Peptides comprising a subsequence of human cartilage glycoprotein - 39
IL116126A0 (en) * 1995-11-24 1996-01-31 Yeda Res & Dev Process for the preparation of bacteriochlorophyllis some novel compounds of this type and pharmaceutical compositions comprising them

Also Published As

Publication number Publication date
NO20012807D0 (no) 2001-06-07
PT1137411E (pt) 2007-02-28
SI1137411T1 (sl) 2007-10-31
PL348201A1 (en) 2002-05-06
CA2353554A1 (en) 2000-06-15
HK1040638B (en) 2007-06-15
CN1160069C (zh) 2004-08-04
HUP0105411A2 (hu) 2002-04-29
BR9916096A (pt) 2001-11-13
EP1137411B1 (en) 2006-12-06
HU228208B1 (en) 2013-01-28
AU1583400A (en) 2000-06-26
NO331426B1 (no) 2011-12-27
WO2000033833A1 (en) 2000-06-15
BRPI9916096B8 (pt) 2021-05-25
DE69934328D1 (de) 2007-01-18
EP1137411A4 (en) 2003-04-23
HK1040638A1 (en) 2002-06-21
US6569846B1 (en) 2003-05-27
ES2277454T3 (es) 2007-07-01
DE69934328T2 (de) 2007-07-19
EP1137411A1 (en) 2001-10-04
JP2002531497A (ja) 2002-09-24
RU2234508C2 (ru) 2004-08-20
AU771292B2 (en) 2004-03-18
PL201172B1 (pl) 2009-03-31
ATE347554T1 (de) 2006-12-15
JP4796227B2 (ja) 2011-10-19
DK1137411T3 (da) 2007-03-26
BR9916096B1 (pt) 2013-11-19
NO20012807L (no) 2001-08-08
IL143591A0 (en) 2002-04-21
CA2353554C (en) 2011-04-26
CN1334728A (zh) 2002-02-06
NZ512093A (en) 2003-04-29
HUP0105411A3 (en) 2003-12-29

Similar Documents

Publication Publication Date Title
NZ512093A (en) Palladium-substituted bacteriochlorophyll derivatives and use thereof
CY1109153T1 (el) Ενωσεις υποκατεστημενου κυκλοπεντανιου και κυκλοπεντενιου χρησιμες ως αναστολεις νευραμινιδασης
NL300178I2 (nl) Nieuwe peptidederivaten.
FI853622L (fi) Diarylacetylener, deras framstaellning och anvaendning.
CY1105948T1 (el) Παραγωγα φαινυλακεταμιδο-θειαζολης, διepγασια για την παρασκευη τους και η χρηση τους ως παραγοντων κατα των ογκων
ES2148476T3 (es) Derivados de azabicicloalcano n-substituidos como neurolepticos asf.
ES2070186T3 (es) Nuevos derivados de 2,4-diamino-pirimidina-3-oxido y su utilizacion en la prevencion de la caida de los cabellos.
EA199900620A1 (ru) Фталазиноны
DE69431316D1 (de) Amidderivate und ihre therapeutische Verwendung
ES2182835T3 (es) Derivados de acridinio y su utilizacion en inmunoensayos de luminiscencia.
ES538290A0 (es) Procedimiento para la obtencion de tetrahidrobenzindoles
MX25770A (es) Compuestos antidiabeticos y procedimientos para supreparacion.
NO20022976L (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
ES2011448B3 (es) Preparacion de un compuesto heterocido y uso del mismo
IT1140535B (it) Derivati benzoazepinici
ATE188217T1 (de) 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate
ATE189203T1 (de) Trizyklische derivate, ihre herstellung, ihre verwendung zur herstellung von optisch aktivem oder racemischem colchizin, thiocolchizin, dessen analoge oder derivate, und intermediate
ES2062819T3 (es) Compuestos heterociclicos, y su preparacion y uso.
FI874123A0 (fi) Heptanoyl-glu-asp-ala-aminosyra -immunostimulanter.
ATE239768T1 (de) Neue triphendisoxazinpigmente
IT8683362A0 (it) Procedimento e uso di un colorante naturale rosso ad alta intensita'derivato dalla coltura dei tessuti cellulari di carota.
ES2061722T3 (es) Derivados de fenantridina, procedimiento para su obtencion y agentes para la realizacion del procedimiento.
ES2178335T3 (es) Utilizacion de sulfobetalinas como agentes antitranspirantes.
NO863647L (no) Propanolderivater.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.